Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Bajaj Healthcare Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: BAJAJHCARE Small Cap ISIN: INE411U01027
As on 12 February 2025 at 03:47 IST
As on 12 February 2025 at 03:47 IST
591
-33.05
(-5.30%)
Over 1 Month
12.28%
Over 6 Months
47.84%
Over 1 Year
89.36%
Over 3 Years
45.85%

Bajaj Healthcare Ltd Summary

Close ₹ 591
Open ₹ 634.90
High ₹ 634.90
Low ₹ 586.65
Volume 2,10,258
Net Turnover (in ₹ Cr) ₹ 12.61
52Wk High ₹ 719
52Wk Low ₹ 263.30
52Wk High / Low
263.30
719

Bajaj Healthcare Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,866.57
EPS (TTM) 10.84
Book Value (BV) 141.16
Div. Yield 0.15 %
P/E (TTM) -120.06
Price/Book Value 4.18
Delivery % 41.58 %
Face Value 5

Key Ratios

PE Ratio -
PB Ratio 2.90
EV to Sales 2.40
PEG Ratio -
ROA -12.76
ROE -12.23
Debt-Equity 1.16
Net Profit Margin -8.34
Operating Profit Margin 17.95

Bajaj Healthcare Ltd Financials

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue482.10647.39681.33663.90416.54
Total Expenses454.45569.20591.65545.08380.48
Profit Before Tax-16.6878.1889.68118.8236.06
Profit After Tax-14.3363.5371.3983.1125.24
Operating Profit after Depreciation57.3395.74102.31127.1242.51

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets254.57367.07269.74208.13162.24
Total Non Current Assets360.59397.26322.79267.30174.53
Total Current Assets404.54500.40398.31258.33168.42
TOTAL ASSETS765.13897.66721.10525.63342.95
Total Shareholder's Fund278.36367.69328.49258.41177.93

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities92.29-22.190.6943.5620.57
Net Cash used in Investing Activities-11.24-93.43-74.80-108.93-27.56
Net Cash used in Financing Activities-96.60131.3761.8575.463.28

No data available

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue122.79133.09132.25133.90108.57
Total Expenses104.39108.56108.63117.8696.76
Profit Before Tax8.4113.579.30-33.07-1.39
Profit After Tax11.729.467.13-29.92-2.20
Operating Profit after Depreciation20.7728.2624.4724.5712.61

Bajaj Healthcare Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 606.73
S2 589.42
S3 565.28
Pivot 630.87
R1 648.18
R2 672.32
R3 689.63

Moving Average

20 SMA 627.97
50 SMA 565.76
100 SMA 472.44
200 SMA 411.17

Bajaj Healthcare Ltd Corporate Actions

Bajaj Healthcare Ltd

₹1/Share

Announcement Date 23 Sep 2024
Record Date 24 Sep 2024
Div Yield 20%

Bajaj Healthcare Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Bajaj Healthcare Ltd ₹590.70 ₹1,865.62
Sun Pharmaceuticals Industries Ltd ₹1,699.75 ₹4,07,826.96
Divis Laboratories Ltd ₹5,949.15 ₹1,57,931.24
Cipla Ltd ₹1,452.70 ₹1,17,322.09
Torrent Pharmaceuticals Ltd ₹3,104.95 ₹1,05,080.90
Mankind Pharma Ltd ₹2,451.35 ₹1,01,134.59

Bajaj Healthcare Ltd News

Bajaj Healthcare to table results

On 11 February 2025

07 Feb 2025, 10:48 am

Bajaj Healthcare gets DGCI nod for manufacturing of Pimavanserin in India

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

30 Jan 2025, 01:32 pm

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin in India

30 Jan 2025, 09:24 am

Bajaj Healthcare hits record high after receiving rights to manufacture Magtein in India

Bajaj Healthcare soared 13.41% to Rs 637.25 after the company said that it has received exclusive rights for manufacturing, distribution & sales of the finished formulation of the product magnesium L Threonate (Magtein) in India from Threotech LLC.

17 Jan 2025, 11:50 am

Bajaj Healthcare hits 52-week high on TGA nod for Vadodara unit

Bajaj Healthcare rallied 3.63% to Rs 447.75 after the company's Active Pharmaceutical Ingredient (API) manufacturing site at Savli, Vadodara in Gujarat received approval from Therapeutic Goods Administration (TGA), Australia.

09 Dec 2024, 12:39 pm

Bajaj Healthcare Ltd Stock Analysis

  1. Annual revenue for Bajaj Healthcare Ltd decreased by 25.53% to ₹482.10 crore in FY 2024 from ₹647.39 crore in FY 2023.
  2. Annual Net Profit for Bajaj Healthcare Ltd decreased by 122.55% to ₹-14.33 crore in FY 2024 from ₹63.53 crore in FY 2023.
  3. Promoter Shareholding in Bajaj Healthcare Ltd remains unchanged by 0.00% in the most recent quarter, from 59.19% in September 2024 to 59.19% in December 2024.
  4. Bajaj Healthcare Ltd delivered a 1-year return of 89.36% compared to the Nifty 50, which provided a return of 6.73% as of the last trading session.
  5. Bajaj Healthcare Ltd share price moved down by 5.30% from its previous close of INR ₹624.05. The latest Bajaj Healthcare Ltd share price is INR ₹591.
  6. Bajaj Healthcare Ltd share price today has been at a low of 586.65 and a high of 634.90. Over the past 52 weeks, the Bajaj Healthcare Ltd share price has seen a low of 263.30 and a high of 719.

FAQ’s

What is the share price of Bajaj Healthcare Ltd today?

Bajaj Healthcare Ltd share price as on 11 Feb 2025 is ₹ 591

What is the Market Cap of Bajaj Healthcare Ltd?

The market cap of Bajaj Healthcare Ltd stock is ₹1,866.57 Cr.

What is the PE Ratio of Bajaj Healthcare Ltd?

The Price to Earnings (P/E) Ratio of Bajaj Healthcare Ltd is -

What is the PB Ratio of Bajaj Healthcare Ltd?

The Price to Book (P/B) Ratio of Bajaj Healthcare Ltd is 2.90

What is the 52 week high of Bajaj Healthcare Ltd Share Price?

The 52 week high of Bajaj Healthcare Ltd share price stands at ₹719

What is the 52 week low of Bajaj Healthcare Ltd Share Price?

The 52 week low of Bajaj Healthcare Ltd share price stands at ₹263.30

Get started with us today and
start building your wealth journey